{
    "version": "1.0",
    "type": "rich",
    "width": 0,
    "height": 0,
    "html": false,
    "provider_name": "ReleaseWire",
    "provider_url": "http:\/\/www.releasewire.com\/",
    "title": "Global Chronic Myelogenous Leukemia Treatment Market 2017: Bristol-Myers Squibb, Novartis AG, Pfizer Inc., Teva Pharmaceuticals, Roche Holdings AG, Incyte Corp",
    "author_name": "Markets N Research",
    "author_url": "http:\/\/www.marketsnresearch.com\/"
}